SCHEMBL1400583

SCHEMBL1400583

O=C1OCCCC1Br

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2026994 0.93
SCHEMBL16594820 0.84
SCHEMBL136614 0.84
SCHEMBL16594819 0.84
SCHEMBL20982184 0.76 CA1 (0.31)
SCHEMBL10804172 0.72
SCHEMBL2057940 0.70
SCHEMBL1092664 0.70
SCHEMBL5818763 0.70
SCHEMBL981115 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 79 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11759454-B2 Diazole lactams CHEMOCENTRYX, INC. (US) 2023-09-19 US disclosed
US-20210093613-A1 DIAZOLE LACTAMS CHEMOCENTRYX, INC. 2021-04-01 US disclosed
US-10744118-B2 Diazole lactams CHEMOCENTRYX, INC. (US) 2020-08-18 US disclosed
EP-2928474-B1 DIAZOLE LACTAMS CHEMOCENTRYX INC (US) 2018-11-14 EP disclosed
CN-107922366-A Pyruvate dehydrogenase kinase inhibitor and application thereof 华东理工大学 2018-04-17 CN disclosed
US-20160303084-A1 DIAZOLE LACTAMS CHEMOCENTRYX, INC. 2016-10-20 US disclosed
US-9328116-B2 Diazole lactams CHEMOCENTRYX, INC. (US) 2016-05-03 US disclosed
EP-2928474-A1 DIAZOLE LACTAMS ChemoCentryx, Inc. (US) 2015-10-14 EP disclosed
EP-2507669-B1 ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, FILM FORMED USING THE COMPOSITION AND PATTERN FORMING METHOD USING THE SAME FUJIFILM CORP (JP) 2015-01-07 EP disclosed
US-20140171420-A1 DIAZOLE LACTAMS CHEMOCENTRYX, INC. (US) 2014-06-19 US disclosed
EP-1578715-A2 INDANE ACETIC ACID DERIVATIVES AND THEIR USE AS PHARMACEUTICAL AGENTS, INTERMEDIATES, AND METHOD OF PREPARATION Bayer Pharmaceuticals Corporation (US) 2005-09-28 EP disclosed
WO-2004058174-A2 INDANE ACETIC ACID DERIVATIVES AND THEIR USE AS PHARMACEUTICAL AGENTS, INTERMEDIATES, AND METHOD OF PREPARATION BAYER PHARMACEUTICALS CORPORATION (US) 2004-07-15 WO disclosed
EP-0839806-B1 Substituted tricyclics LILLY CO ELI (US) 2003-07-09 EP disclosed
WO-1998018464-A1 SUBSTITUTED TRICYCLICS ELI LILLY AND COMPANY (US) 1998-05-07 WO disclosed
EP-0839806-A1 Substituted tricyclics ELI LILLY AND COMPANY (US) 1998-05-06 EP disclosed
US-4551452-A Anti-inflammatory 2-methyl-2H-1,2-benzo-(or -thieno-)thiazine-3-carboxamide 1,1-dioxide derivatives, compositions, and method of use therefor PFIZER INC. (US) 1985-11-05 US disclosed
US-4180579-A 2-Substituted-1H-benz[de]-isoquinoline-1,3(2H)-diones E. R. SQUIBB & SONS, INC. (US) 1979-12-25 US disclosed
US-4170651-A ANTIINFLAMMATORY AGENTS E. R. SQUIBB & SONS, INC. (US) 1979-10-09 US disclosed
US-4115555-A ANTIINFLAMMATORY E. R. SQUIBB & SONS, INC. (US) 1978-09-19 US disclosed
US-4051246-A ANTIINFLAMMATORY E. R. SQUIBB & SONS, INC. (US) 1977-09-27 US disclosed